• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

How eClinicalWorks Agentic AI Is Helping Revenue Cycle Leaders Improve Financial Performance
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

LinusBio, Coralis Health Partner to Reduce Autism Diagnosis Waitlists

by Jasmine Pennic 08/05/2025 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know: 

– LinusBio, a leader in precision exposome medicine, and Coralis Health, a pioneering virtual care platform for neurodivergent children and families, today announced a partnership to provide comprehensive, end-to-end diagnostic services for autism spectrum disorder (ASD). 

– The collaboration combines LinusBio’s breakthrough ClearStrand-ASD™ biomarker test with Coralis Health’s specialized care platform, creating a seamless pathway from early screening to diagnosis and intervention.

Streamlining the Path from Screening to Intervention

Evidence shows that early diagnosis and intervention are crucial for improved outcomes, yet many families face lengthy delays in accessing diagnostic support. Currently, waitlists for diagnostic evaluations can be years long, delaying access to critical early interventions. This new partnership creates a direct bridge between biomarker screening and comprehensive virtual diagnostic services, significantly reducing the time between initial concern and professional evaluation.

Once ClearStrand-ASD results are available, LinusBio directly refers qualifying families to Coralis Health. Coralis Health’s virtual diagnostic teams reach out within five calendar days to schedule intake appointments and complete comprehensive evaluations within 90 days. The integrated service is designed for families who have concerns about their child’s development and are seeking both objective screening insights and expert diagnostic evaluation. Healthcare and service providers can also leverage this streamlined pathway to offer their patients a comprehensive diagnostic solution that reduces referral complexity and wait times.

Dr. Ayesha Cheema-Hasan, founder and CEO of Coralis Health, explained, “Our goal has always been to make sure that children are connected to life-changing therapies in a timely manner, while providing the highest quality care. We also want to reduce the burden on clinicians, by finding ways to standardize care in a space that’s currently too dependent on individual clinical expertise and training. By leveraging technology thoughtfully, we aim to bridge the gap in access, and ensure that every child has the opportunity to thrive regardless of where they start.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

How eClinicalWorks Agentic AI Is Helping Revenue Cycle Leaders Improve Financial Performance

Most-Read

Innovaccer-CHIME 2030 Survey Reveals AI Will Automate Nearly Two-Thirds of Administrative Work and Do 3x the Work With the Same Staff

Innovaccer-CHIME 2030 Survey Reveals AI Will Automate Nearly Two-Thirds of Administrative Work and Do 3x the Work With the Same Staff

CB Insights’ 2026 Digital Health 50 Reveals How Agentic AI Is Becoming the Clinical Provider and Medication Access Engine

Oura Acquires Counsel Health for $625M: Scaling Continuous Biometrics into On-Demand Medical Care

M&A: Oura Acquires Counsel Health for $625M: Scaling Continuous Biometrics into On-Demand Medical Care

WittKieffer 2026 Healthcare CIO Survey: 82% Sit on Executive Teams, Yet Only 36% Have Formal Succession Plans

WittKieffer 2026 Healthcare CIO Survey: 82% Sit on Executive Teams, Yet Only 36% Have Formal Succession Plans

CVS Rebrands Health Services Segment, Launches Model for Retail Pharmacy Reimbursement

CVS Health Formalizes Tax-Free Split-Off to Carve Out CVS Pharmacy by 2028

SAMHSA and ONC Invest $20M in Behavioral Health IT Initiative

ONC Finalizes HTI-5 Deregulatory Rule to Cut $1.55B in Health IT Compliance and Accelerate FHIR APIs

Redesign Health Merges with Sheba Medical Center’s ARC Global and Agrees to Acquire AVIA

Redesign Health Merges with Sheba Medical Center’s ARC Global and Agrees to Acquire AVIA

Sword Acquires Headspace in All-Cash Deal Worth Up to $300M to Unify Physical and Mental AI Care

M&A: Sword Acquires Headspace in All-Cash Deal Worth Up to $300M to Unify Physical and Mental AI Care

M&A: Francisco Partners to Acquire Weave in $650M Take-Private Deal

M&A: Francisco Partners to Acquire Weave in $650M Take-Private Deal

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Secondary Sidebar

Footer

Company

  • About Us
  • 2026 Editorial Calendar
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2026. HIT Consultant Media. All Rights Reserved. Privacy Policy |